Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
September 8, 2016
Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era
Raymond R Townsend, Murray Epstein
The Medical Clinics of North America
|
February 12, 2004
Evolving role of calcium antagonists in the management of hypertension
Murray Epstein, Vito M Campese
Nature Reviews. Nephrology
|
February 22, 2012
Statins in the management of dyslipidemia associated with chronic kidney disease
Murray Epstein, Nosratola D Vaziri
The American Journal of Medicine
|
February 23, 2016
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
Murray Epstein, Daniel A Duprez
European Heart Journal
|
June 30, 2016
A propitious time for initiating clinical trials in patients with heart failure with reduced ejection fraction and an estimated glomerular filtration rate <30 mL/min with an mineralocorticoid receptor antagonist and a K+ binder: 'the forbidden fruit'
Murray Epstein, Bertram C Pitt
Nephrology News & Issues
|
June 4, 2016
Arrhythmias and sudden cardiac death in hemodialysis patients. Temporal profile, electrolyte abnormalities, and potential targeted therapies
Murray Epstein, Prabir Roy-Chaudhury
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 8, 2005
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function
Murray Epstein, Vito M Campese
Kidney International Supplements
|
March 23, 2022
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
Morley D Hollenberg, Murray Epstein
Kidney International Reports
|
November 17, 2017
The Unappreciated Role of Extrarenal and Gut Sensors in Modulating Renal Potassium Handling: Implications for Diagnosis of Dyskalemias and Interpreting Clinical Trials
Murray Epstein, Meyer D Lifschitz
Hypertension (Dallas, Tex. : 1979)
|
April 12, 2006
Aldosterone and large artery vessels
Murray Epstein, Michel E Safar
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Hypertension (Dallas, Tex. : 1979)
|
September 8, 2016
Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era
Raymond R Townsend, Murray Epstein
The Medical Clinics of North America
|
February 12, 2004
Evolving role of calcium antagonists in the management of hypertension
Murray Epstein, Vito M Campese
Nature Reviews. Nephrology
|
February 22, 2012
Statins in the management of dyslipidemia associated with chronic kidney disease
Murray Epstein, Nosratola D Vaziri
The American Journal of Medicine
|
February 23, 2016
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
Murray Epstein, Daniel A Duprez
European Heart Journal
|
June 30, 2016
A propitious time for initiating clinical trials in patients with heart failure with reduced ejection fraction and an estimated glomerular filtration rate <30 mL/min with an mineralocorticoid receptor antagonist and a K+ binder: 'the forbidden fruit'
Murray Epstein, Bertram C Pitt
Nephrology News & Issues
|
June 4, 2016
Arrhythmias and sudden cardiac death in hemodialysis patients. Temporal profile, electrolyte abnormalities, and potential targeted therapies
Murray Epstein, Prabir Roy-Chaudhury
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 8, 2005
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function
Murray Epstein, Vito M Campese
Kidney International Supplements
|
March 23, 2022
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
Morley D Hollenberg, Murray Epstein
Kidney International Reports
|
November 17, 2017
The Unappreciated Role of Extrarenal and Gut Sensors in Modulating Renal Potassium Handling: Implications for Diagnosis of Dyskalemias and Interpreting Clinical Trials
Murray Epstein, Meyer D Lifschitz
Hypertension (Dallas, Tex. : 1979)
|
April 12, 2006
Aldosterone and large artery vessels
Murray Epstein, Michel E Safar
Page
of 8